The genus Streptomyces is recognized as the most important bacterial source of clinically used therapeutics, including lifesaving antibiotics and antifungal, anticancer, and immunosuppressive agents [1] . Endophytes are also considered as an important natural source to obtain a variety of secondary metabolites [2] . The endophytic Streptomyces sp. YIM61470 was isolated from Maytenus hookeri, and its broth culture exhibited antimicrobial activity with a zone of inhibition towards Candida albicans of 12 mm at a concentration of 10 mg/mL in an antimicrobial agar diffusion assay. As part of our persistent search for new and active natural products from Actinomycetes, a chemical investigation of the secondary metabolites from this bacterium was carried out. Six compounds were isolated and determined as (R)-1-O-(phenyl acetyl) glycerol (1) [3] , 4',5-dihydroxy-6-(3,3dimethylallyl)-7-methoxyflavanone (2) [4], (32R,33R,34S)-32,33,34,35-bacteriohopanetetrol (3) [5] , MKN-003C (4) [6] , cyclo(L-Pro-L-Gly) (5) [7] and cyclo(L-Pro-L-Tyr) (6) [8] . Compound 1 was isolated from a natural source for the first time. The antimicrobial activities of 1-6 against Candida albicans and Bacillus coli were evaluated ( Table 1 ).
The molecular formula C 11 H 14 O 4 of 1 was determined from its HREIMS, together with the NMR data. Analysis of its 13 C NMR data indicated the presence of one carbonyl at δ173.9, one olefinic quaternary carbon at δ 136.0, five olefinic methines at δ 130.8 (2CH), 129.9 (2CH), 128.5 (CH), and one methylene at δ 42.2 for a monosubstituted phenylacetic acid. The methine at δ 71.5 and the two methylenes at δ 67.3 and 64.5 were for glycerol. The configuration of 1 was determined as R ([] 25 D -28.4) by comparison with the optical rotation of (R)-1-benzoyloxy-2,3-propanediol, the analog of 1([] 20 D -13.8) [9] , and so the structure of compound 1 was elucidated as (R)-1-O-(phenylacetyl)glycerol, which has been synthesized by the lipase-mediated desymmetrization of glycerol [3] . deposited in Yunnan Institute of Microbiology. YIM 61470 was cultivated on a 40 L scale using 1 L Erlenmeyer flasks containing 500 mL of the seed medium (yeast extract 0.4%, glucose 0.4%, malt extract 0.5%, decavitamin 0.01%, pH 7.2) at 28°C for 3 days on rotary shakers (250 rpm) and fermentation medium (soluble starch 0.5%, glucose 2%, soybean powder 0.3%, beef extract 0.3%, yeast extract 0.2%, NaCl 0.4%, CaCO 3 0.2%, K 2 HPO 3 0.05%, MgSO 4 0.05%, pH 7.8) at 28°C for 7 days on rotary shakers (250 rpm).
Extraction and isolation of compounds: After 10 days of growth, the fermentation broth (40L) was filtered to separate the mycelium and filtrate. The mycelium was extracted with acetone, and the acetone extract (12.4 mg) was separated by silica gel CC to yield 5 fractions (Fr. Sephadex LH-20 (CH 3 OH) to afford compounds 3 (2.7 mg), 4 (2.1 mg), 5 (4.5 mg), and 6 (1.7 mg).
Antimicrobial assays:
The antimicrobial assays were performed in 96-well sterilized microplates using a microdilution method, as described previously [10] . 
